Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age
Conditions: Measles; Rubella; Rubella Syndrome, Congenital Interventions: Biological: Measles-rubella (MR) vaccine at 6 and 9 months; Biological: Measles-rubella (MR) vaccine at 9 months Sponsors: Centers for Disease Control and Prevention; The International Centre for Diarrhoeal Disease Research, Bangladesh; Ministry of Health and Family Welfare, Bangladesh Not yet recruiting - verified March 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials